Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 28 tags : Earnings save search
Off to Stratospheric 2022 Start, AbbVie Announces New Protein Degradation Partnership
Published: 2022-04-28 (Crawled : 15:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
partnership
Alnylam Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity
Published: 2022-04-28 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.41%
H: 0.65%
C: 0.14%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -2.65%
H: 3.28%
C: -0.84%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: -2.94%
H: 0.63%
C: -4.79%
results
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year
Published: 2022-04-28 (Crawled : 13:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: -0.89%
H: 2.65%
C: 1.22%
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
Published: 2022-04-28 (Crawled : 13:00) - biospace.com/
CVAC | $2.585 2.17% 2.13% 610K
|
Health Technology
|
| O: -0.43%
H: 4.66%
C: 2.98%
Angle PLC Announces Preliminary Results - Apr 28, 2022
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
ANPCF | News | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
ANPCY | News | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
results
Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 4.44%
H: 1.53%
C: 0.43%
RIGL | $1.135 0.44% 0.44% 520K
|
Health Technology
|
| O: -1.38%
H: 0.2%
C: -2.39%
DTIL | $10.33 6.72% 6.29% 31K
|
Health Technology
|
| O: -0.47%
H: 0.95%
C: -0.95%
results
Merck Announces First-Quarter 2022 Financial Results
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.96%
H: 0.0%
C: 0.0%
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: 2.49%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -2.36%
H: 0.0%
C: 0.0%
results
MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
MNKD | $4.15 0.97% 0.96% 1M
|
Health Technology
|
| O: 0.79%
H: 1.87%
C: 0.94%
conference corporation results
West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
WST | $390.2 4.01% 0.0% 430K
|
Health Technology
|
| O: -1.31%
H: 1.18%
C: -1.73%
results
Thermo Fisher Scientific Reports First Quarter 2022 Results
Published: 2022-04-28 (Crawled : 11:00) - biospace.com/
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
|
| O: 7.63%
H: 0.0%
C: 0.0%
results
Cutera, Inc. to Announce First Quarter Results on May 10, 2022
Published: 2022-04-28 (Crawled : 10:00) - biospace.com/
CUTR | $2.15 10.83% 9.77% 800K
|
Health Technology
|
| O: -2.08%
H: 0.0%
C: -5.55%
results
argenx to Report First Quarter 2022 Financial Results and Business Update on May 5, 2022
Published: 2022-04-28 (Crawled : 10:00) - biospace.com/
ARGX | $375.13 1.73% 1.7% 340K
|
Health Technology
|
| O: -2.65%
H: 0.33%
C: -0.79%
report results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.